NewsRx

Search our medical news database

Savient Pharmaceuticals, Inc.

Pharmaceutical company receives Nasdaq notice on third quarter 10-Q filing delay

Published in Elder Law Weekly, December 21st, 2005

Savient Pharmaceuticals, Inc. (SVNTE) announced that it has received a Nasdaq staff determination letter regarding the company's failure to file its quarterly report on Form 10-Q on time for the period ended September 30, 2005.

This notice was expected and is routinely issued by Nasdaq to companies engaged, as Savient is, in regaining compliance with Nasdaq's listing qualifications. The Nasdaq Listing Qualifications Panel has previously granted the company an extension to file this quarterly report by no later than January 3, 2006.

Savient announced on August 19, 2005 that it had received a Nasdaq Staff Determination Letter stating that it was not in...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Elder Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook